Medicare Enrolled
Dr. Steven Urbaniak, D.O.
Neurology · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Urbaniak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Urbaniak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Urbaniak
Dr. Steven Urbaniak is a neurology specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Urbaniak performed 1,611 Medicare services across 1,409 unique beneficiaries.
Between the years covered by Open Payments, Dr. Urbaniak received a total of $22,422 from 73 pharmaceutical and/or device companies across 1347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Urbaniak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in PA
$22,422 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,611
Medicare services
Top 8% in PA for neurology
1,409
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
347 | $35 | $7,537 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $67 | $150 |
| Limited needle electromyography A test that measures the electrical activity in muscles of the arm, leg, trunk, or head using a needle electrode. This limited study evaluates muscle function and nerve health. |
220 | $15 | $1,641 |
| Nerve-muscle junction testing A diagnostic test used to evaluate the function of the connection between nerves and muscles. |
182 | $26 | $902 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
141 | $90 | $11,383 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
94 | $115 | $350 |
| Intraoperative EEG monitoring Recording brain wave activity during surgery to monitor neurological function. |
58 | $42 | $6,259 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
57 | $63 | $2,721 |
| ECG, 1-3 leads with physician review A simple electrocardiogram recording using one to three leads. A physician reviews the results. |
44 | $6 | $50 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
37 | $82 | $165 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
31 | $317 | $635 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $90 | $230 |
| Central motor stimulation test of legs This procedure involves placing skin electrodes on the body to measure how electrical signals travel through the central nervous system to the leg muscles. |
14 | $62 | $7,529 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
13 | $364 | $745 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,422
Total received (2018-2024)
Avg $3,203/year across 7 years
Top 15% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,876 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$546 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,270
2023
$3,529
2022
$3,853
2021
$3,701
2020
$1,900
2019
$2,326
2018
$3,843
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$500
Novartis Pharmaceuticals Corporation
$284
EMD Serono, Inc.
$256
Neurocrine Biosciences, Inc.
$255
Lilly USA, LLC
$249
SK Life Science, Inc.
$222
Lundbeck LLC
$179
Kyowa Kirin, Inc.
$153
GE HEALTHCARE
$131
MDD US Operations, LLC
$126
PFIZER INC.
$125
E.R. Squibb & Sons, L.L.C.
$107
Celgene Corporation
$107
UCB, Inc.
$106
Alexion Pharmaceuticals, Inc.
$101
Biogen, Inc.
$81
Teva Pharmaceuticals USA, Inc.
$72
Amneal Pharmaceuticals LLC
$47
Neurelis, Inc.
$37
Merz Pharmaceuticals, LLC
$33
Acorda Therapeutics, Inc
$31
ACADIA Pharmaceuticals Inc
$26
Eisai Inc.
$21
Vanda Pharmaceuticals Inc.
$20
Top 3 companies account for 31.8% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,445
Teva Pharmaceuticals USA, Inc.
$1,339
UCB, Inc.
$1,277
Novartis Pharmaceuticals Corporation
$1,262
EMD Serono, Inc.
$1,109
UPSHER-SMITH LABORATORIES LLC
$977
Lilly USA, LLC
$940
ABBVIE INC.
$825
AbbVie Inc.
$723
Alexion Pharmaceuticals, Inc.
$705
SK Life Science, Inc.
$677
Neurocrine Biosciences, Inc.
$654
Avanir Pharmaceuticals, Inc.
$646
IMPEL PHARMACEUTICALS INC.
$624
GENZYME CORPORATION
$590
Amgen Inc.
$586
E.R. Squibb & Sons, L.L.C.
$496
Biohaven Pharmaceuticals, Inc.
$495
Upsher-Smith Laboratories LLC
$494
Acorda Therapeutics, Inc
$486
Janssen Pharmaceuticals, Inc
$483
Sunovion Pharmaceuticals Inc.
$448
Lundbeck LLC
$415
Celgene Corporation
$358
Allergan, Inc.
$310
Kyowa Kirin, Inc.
$259
Sumitomo Pharma America, Inc.
$244
Egalet US Inc
$239
Promius Pharma LLC
$223
Mallinckrodt Hospital Products Inc.
$195
Biohaven Pharmaceutical Holding Company Ltd.
$194
PFIZER INC.
$191
Allergan Inc.
$190
MDD US Operations, LLC
$182
ACADIA Pharmaceuticals Inc
$147
Eisai Inc.
$142
GE HEALTHCARE
$131
Genentech USA, Inc.
$120
Neurelis, Inc.
$117
Impax Laboratories, Inc.
$107
US WorldMeds, LLC
$104
Amneal Pharmaceuticals LLC
$88
Adamas Pharmaceuticals, Inc.
$85
Merz North America, Inc.
$80
Mallinckrodt Enterprises LLC
$76
Supernus Pharmaceuticals, Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$74
Iroko Pharmaceuticals, LLC
$74
Assertio Therapeutics, Inc.
$69
GE HealthCare
$68
EISAI INC.
$54
Corium, LLC
$47
TG THERAPEUTICS, INC.
$44
Zyla Life Sciences
$42
Avion Pharmaceuticals
$41
Merz Pharmaceuticals, LLC
$33
TerSera Therapeutics LLC
$32
Bausch Health US, LLC
$29
AQUESTIVE THERAPEUTICS, INC.
$25
CSL Behring
$24
Mylan Pharmaceuticals Inc.
$21
Vertical Pharmaceuticals, LLC
$21
Vanda Pharmaceuticals Inc.
$20
Mallinckrodt LLC
$20
Abbott Laboratories
$20
ASSERTIO THERAPEUTICS, INC.
$18
Mitsubishi Tanabe Pharma America, Inc.
$15
Medtronic USA, Inc.
$15
Banner Life Sciences, LLC
$14
AbbVie, Inc.
$14
Currax Pharmaceuticals LLC
$12
Collegium Pharmaceutical, Inc.
$12
CATALYST PHARMACEUTICALS, INC.
$11
Top 3 companies account for 18.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · Cambia · Dhivy · ELYXYB - celecoxib · EMGALITY · FIRDAPSE · Fycompa · GEMTESA · GILENYA · GOCOVRI · Glatiramer Acetate · Gocovri · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · METHYLPHENIDATE 72 · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ongentys · PLEGRIDY · PONVORY · PRIALT · PROCLAIM · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SYMPAZAN · Soliris · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VIVLODEX · VUMERITY · VYEPTI · Vimpat · XCOPRI · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
527
Per 100K population
33.3
County median income
$60,698
Nearest hospital
NAZARETH HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Urbaniak is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 15% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Urbaniak experienced with placement of skin electrodes and measurement of stimulated sites on arms and legs?
Based on Medicare claims data, Dr. Urbaniak performed 347 placement of skin electrodes and measurement of stimulated sites on arms and legs services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Urbaniak receive payments from pharmaceutical companies?
Yes. Dr. Urbaniak received a total of $22,422 from 73 companies across 1,347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Urbaniak's costs compare to other neurologists in Philadelphia?
Dr. Urbaniak's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Urbaniak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Philadelphia
Browse neurologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology